Skip to Main Content

Paper Details

Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer.
Eur Urol Oncol
29
2022
Author NameAffiliation
Chul AhnUniversity of Texas Southwestern Medical Center
  • 1 - 1

Datasets

Release 1.2